Inhaled nanoparticles are primarily explored for drug delivery systems, particularly for treating respiratory diseases such as asthma, tuberculosis, and lung cancer. By delivering medication directly to the lungs, the efficacy of the treatment can be significantly enhanced while minimizing side effects. Additionally, inhaled nanoparticles are being studied for their potential in vaccination and gene therapy, where they can deliver DNA or RNA molecules to target cells.
